Millennium Management »

Enlivex Therapeutics shares owned by Millennium Management

Quarter-by-quarter ownership of Enlivex Therapeutics (ENLV) shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Enlivex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enlivex Therapeutics held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enlivex Therapeutics by Millennium Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $11k 12k 0.93
2025-06-30 $686k 612k 1.12
2025-03-31 $649k 669k 0.97
2024-12-31 $742k 634k 1.17

More positions owned by Millennium Management

Astrazeneca Ord Put Option (AZN)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple Put Option (AAPL)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Amazon Call Option (AMZN)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Select Sector Spdr Tr State Street Fin Put Option (XLF)
Broadcom (AVGO)
Select Sector Spdr Tr State Street Ene Call Option (XLE)

View all positions for Millennium Management

Top funds holding Enlivex Therapeutics

Diametric Capital
ARK Investment Management
Renaissance Technologies
Two Sigma Investments
UBS Group
Bank of America Corporation
Goldman Sachs Group
Morgan Stanley
Geode Capital Management
XTX Topco
Invesco
Citadel Advisors
Virtu Financial
Two Sigma Securities
Prosperity Consulting Group

View all funds holding Enlivex Therapeutics